Abiopharma

New Form 8-K - Semler Scientific, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-061946 Size: 194 KB Item 8.01: Other Events

New Form RW - Allarity Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001213900-25-056913 Size: 8 KB

Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products

Retirement Of Mr. Lee Keck Keong As Executive Director

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

InnovAge PACE Sponsors Documentary Spotlighting National Crisis in Family Caregiving

EPAM Systems, Inc. - EPAM Releases DIAL 3.0: An Evolution of Open-Source GenAI Enterprise Platform

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Sellas Life Sciences - SELLAS Life Sciences to be Added to Russell3000® and Russell 2000® Indexes

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Semler Scientific® Announces CardioVanta™,a New Entity that Seeks to Unlock Value of Future Medical Business Opportunities

New Form 6-K - ImmunoPrecise Antibodies Ltd. Filed: 2025-06-24 AccNo: 0000950170-25-089224 Size: 64 KB

New Form 8-K - OneMedNet Corp Filed: 2025-06-24 AccNo: 0001641172-25-016223 Size: 833 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits